Tumor necrosis factor-α mediates antiapoptotic signals partially via p38 MAP kinase activation in human eosinophils

International Archives of Allergy and Immunology

Volumn 120, Issue SUPPL. 1, 1999, Pages 54-59

  Tsukahara, Kayo ^a   Nakao, Atsuhito ^a   Hiraguri, Masaki ^a   Miike, Satoshi ^a   Mamura, Mizuko ^a   Saito, Yasushi ^a   Iwamoto, Itsuo ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Eosinophil apoptosis; p38 MAP kinase; Tumor necrosis factor

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ASSAY; CELL CYCLE; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

APOPTOSIS; CELLS, CULTURED; EOSINOPHILS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032884734     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053596     Document Type: Conference Paper

References (26)

1. Tracey K, Cerami A: Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317-343.
2. Silberstein DS, David JR: Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci USA 1986; 83:1055-1059.
3. Horie S, Gleich GJ, Kita H: Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996;98:371-381.
4. Lukacs NW, Strieter RM, Chenusue SW, Widmer M, Kunkel SL: TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995; 154:5411-5417.
5. Gleich GJ: The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Immunol 1990;85:422-436.
6. Cembryznska-Nowak M, Szklarz E, Inglot AD, Teodoczyk-Injeyan JA: Elevated release of tumor necrosis factor-α and interferon-γ by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 1993; 147:291-296.
7. Simon H-U, Yousefi S, Schranz C, Schapowal A, Bachert C, Blase K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997; 158:3902-3908.
8. Van Antwerp DJ, Martin SJ, Verma IM, Green DR: Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol 1998;8:107-111.
9. Hansel TT, De Vries IJM, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C: An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
10. Cuend A, Rouse J, Doza YN, Neier R, Cohen P, Gallagher TF, Young RR, Lee JC: SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229-233.
11. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
12. Hiraguri M, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I: Granulocyte-macrophage colony-stimulating factor and interleukin-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J Allergy Clin Immunol 1997;100:S45-51.
13. Simon HU, Yousefi S, Fibbert B, Levi-Schaffer F, Blaser K: Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur J Immunol 1997;27:3536-3539.
14. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y: Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony stimulating factor. J Immunol 1998;160:5554-5562.
15. Tewari M, Dixit VM: Signaling through members of the tumor necrosis factor receptor family; in Heldin C-H, Purton M (eds): Signal Transduction. London, Chapman & Hall, 1996, pp 79-92.
16. Liu Z-G, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor I effector functions: JNK activation it not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996;87:565-576.
17. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M: Activation of SAPK/JNK by TNF receptor I through a noncytotoxic TRAF2-dependent pathway. Science 1997;275:200-203.
18. Cesaris PD, Starace D, Riccioli A, Padula F, Filippini A, Ziparo E: Tumor necrosis factor-α induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J Biol Chem 1998;27:7566-7571.
19. Carpentier I, Declercq W, Malinin NL, Wallach D, Fiers W, Beyaert R: TRAF2 plays a dual role in NF-κB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkB kinase pathways. FEBS Lett 1998;425:195-198.
20. Nishida E, Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 1993;18:128-131.
21. Roulston A, Reinhard C, Amiri P, Williams LT: Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor-α. J Biol Chem 1998;17:10232-10239.
22. Beyaert R, Kidd VJ, Cornelis S, Van de Craen M, Denecker G, Lahti JM, Gururajan R, Vandenabeele P, Fiers W: The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 1996;15:1914-1923.
23. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996;274:782-784.
24. Wang C-Y, Mayo MW, Baldwin AS Jr: TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 1996; 274:784-787.
25. Antwerp DJV, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996;274:787-789.
26. Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R: Lyn, Jak2, and Raf-1 kinases arc critical for the antiapoptotic effect of interleukin-5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998;188:421-429.